Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A ribosomal protein L21 pseudogene is a genomic sequence similar to the functional RPL21 gene, which encodes a key component of the large (60S) ribosomal subunit. Pseudogenes such as these have lost their protein-coding ability due to disabling mutations and do not produce a functional ribosomal protein. There are many ribosomal protein L21 pseudogenes scattered throughout the human genome, often as a result of retrotransposition (“processed pseudogene”) or genomic duplication (“duplicated pseudogene”). While once dismissed as junk DNA, some pseudogenes are now understood to have potential regulatory roles, such as influencing the expression of their parent gene at the RNA level, though this is not uniformly established or therapeutically actionable for ribosomal protein L21 pseudogenes. These loci are not considered valid therapeutic targets, do not encode proteins, and should not be confused with the functional RPL21 gene, which is clinically relevant. The ribosomal protein L21 pseudogene family consists of non-functional, non-coding DNA elements derived from the RPL21 gene and does not serve as a protein-coding therapeutic target or receptor. They are mostly of academic interest in genomics, with no established clinical or therapeutic significance.
None (pseudogenes are not targeted by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene.